The Journal of Allergy and Clinical Immunology
Volume 122, Issue 6 , Pages 1145-1153.e3, December 2008

Cigarette smoke combined with Toll-like receptor 3 signaling triggers exaggerated epithelial regulated upon activation, normal T-cell expressed and secreted/CCL5 expression in chronic rhinosinusitis

  • Moshe Yamin, PhD

      Affiliations

    • Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, Mass
  • ,
  • Eric H. Holbrook, MD

      Affiliations

    • Massachusetts Eye and Ear Infirmary, Boston, Mass
  • ,
  • Stacey T. Gray, MD

      Affiliations

    • Massachusetts Eye and Ear Infirmary, Boston, Mass
  • ,
  • Rachel Harold, BA

      Affiliations

    • Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, Mass
  • ,
  • Nicolas Busaba, MD

      Affiliations

    • Massachusetts Eye and Ear Infirmary, Boston, Mass
  • ,
  • Avinash Sridhar

      Affiliations

    • Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, Mass
  • ,
  • Katia J. Powell, BS

      Affiliations

    • Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, Mass
  • ,
  • Daniel L. Hamilos, MD

      Affiliations

    • Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, Mass
    • Corresponding Author InformationReprint requests: Daniel L. Hamilos, MD, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, 55 Fruit Street, Bulfinch-422, Boston, MA 02114.

Received 19 February 2008; received in revised form 15 September 2008; accepted 19 September 2008. published online 05 November 2008.

Background

Chronic rhinosinusitis (CRS) is characterized by persistent mucosal inflammation and frequent exacerbations.

Objective

To determine whether innate epithelial responses to cigarette smoke or bacterial or viral pathogens may be abnormal in CRS leading to an inappropriate inflammatory response.

Methods

Primary nasal epithelial cells (PNECs) were grown from middle turbinate biopsies of 9 healthy controls and 11 patients with CRS. After reaching 80% to 90% confluence, PNECs were exposed to medium or cigarette smoke extract (CSE) 5% (vol/vol) for 1 hour, washed, then stimulated with staphylococcal lipoteichoic acid, LPS, or double-stranded RNA (dsRNA). After 24 hours, gene expression was quantified by QRT-PCR.

Results

At baseline, PNECs revealed elevated TNF-α and growth-related oncogene-α (a C-X-C chemokine)/CXCL1 (GRO-α) (4-fold increase, P = .02; and 16-fold increase, P = .004, respectively) in subjects with CRS compared with controls with normal levels of IL-1β, IL-6, IL-8/CXCL8, human β-defensin-2, monocyte chemoattractant protein 2/CCL8, monocyte chemoattractant protein 3/CCL7, and regulated upon activation, normal T-cell expressed and secreted (RANTES)/CCL5. Immunostaining of nasal biopsies, however, revealed comparable epithelial staining for TNF-α, GRO-α, and RANTES. There were no differences in mRNA induction by CSE, TNF-α, lipoteichoic acid, LPS, or dsRNA alone. The combination of CSE+dsRNA induced exaggerated RANTES (12,115-fold vs 1500-fold; P = .03) and human β-defensin-2 (1120-fold vs 12.5-fold; P = .05) in subjects with CRS. No other genes were differentially induced. Furthermore, CSE+dsRNA induced normal levels of IFN-β, IFN-λ1, and IFN-λ2/3 mRNA in subjects with CRS.

Conclusion

Cigarette smoke extract plus dsRNA induces exaggerated epithelial RANTES expression in patients with CRS. We propose that an analogous response to cigarette smoke plus viral infection may contribute to acute exacerbations and eosinophilic mucosal inflammation in CRS.

Key words: Chronic rhinosinusitis, epithelial, innate, cigarette smoke, viral, RANTES, exacerbations, eosinophilic

Abbreviations used: CRS, Chronic rhinosinusitis, CSE, Cigarette smoke extract, dsRNA, Double-stranded RNA (TLR-3 agonist), GAPDH, Glyceraldehyde-3-phosphate dehydrogenase (housekeeping gene), GRO-α, Growth-related oncogene-α (a C-X-C chemokine)/CXCL1, HBD2, Human β-defensin-2, HC, Healthy control, LTA, Lipoteichoic acid, MCP, Monocyte chemoattractant protein, RANTES, Regulated upon activation, normal T-cell expressed and secreted (a C-C chemokine)/CCL5, PNEC, Primary nasal epithelial cell, TLR, Toll-like receptor

 

 Supported by a grant from the Flight Attendants Medical Research Institute.

 Disclosure of potential conflict of interest: D. L. Hamilos has received honoraria from Merck, Critical Therapeutics, Genentech, and Novartis; has consulting arrangements with GlaxoSmithKline, Novartis, Accentia, Schering-Plough, and Sinexus; has received research support from the Flight Attendants Medical Research Institute and Merck; and has received gifts from the GG Monks Foundation to purchase equipment. E. H. Holbrook has received research support from the National Institutes of Health-National Institutes of Deafness and Other Communication Disorders. S. T. Gray has served as a member of the American Academy of Otolaryngology and the American Rhinologic Society. N. Busaba is on the speakers' bureau for Sanofi-Aventis and Schering-Plough. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(08)01728-4

doi:10.1016/j.jaci.2008.09.033

The Journal of Allergy and Clinical Immunology
Volume 122, Issue 6 , Pages 1145-1153.e3, December 2008